{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:55:47Z","timestamp":1790218547709,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":176,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 HL113530"],"award-info":[{"award-number":["UM1 HL113530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL078825"],"award-info":[{"award-number":["P01 HL078825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 HL113530"],"award-info":[{"award-number":["UM1 HL113530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL078825"],"award-info":[{"award-number":["P01 HL078825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cell therapy involves transplantation of human cells to promote repair of diseased or injured tissues and\/or cells. Only a limited number of mostly small-scale trials have studied cell therapy in nonischemic cardiomyopathy (NICM). We performed a meta-analysis of randomized clinical trials (RCTs) to assess the safety and efficacy of cell therapy in NICM. Electronic databases were searched for relevant RCTs from inception until August 2020. Outcomes assessed were left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter or volume (LVEDD), quality of life (QoL) indices, and major adverse cardiac events (MACEs). Weighted mean differences (MDs) and standardized mean differences (SMDs) were calculated using random-effects methods. Eleven RCTs with 574 participants were included in the analysis. There was a significant increase in mean LVEF (MD, 4.17%; 95% confidence interval [CI]\u00a0=\u00a01.66-6.69) and modest decrease in LVEDD (SMD, \u22120.50; 95%\u00a0CI\u00a0=\u00a0\u22120.95 to \u22120.06) in patients treated with cell therapy compared with controls. Cell therapy was also associated with improvement in functional capacity, as assessed by the 6-minute walking distance (MD, 72.49\u2009m; 95%\u00a0CI\u00a0=\u00a03.44-141.53). No significant differences were seen in MACEs and QoL indices between treated and control groups. This meta-analysis suggests that cell therapy may improve LV systolic function and may be associated with improvement in LVEDD and functional capacity compared with maximal medical therapy. Cell therapy was safe, with no significant difference in MACEs between treatment and control groups. However, given the limitations of current studies, larger well-designed RCTs are needed to evaluate the efficacy of cell therapy in patients with NICM.<\/jats:p>","DOI":"10.1002\/sctm.21-0094","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T11:43:06Z","timestamp":1628077386000},"page":"1394-1405","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cell Therapy for Nonischemic Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1093","volume":"10","author":[{"given":"Avnish","family":"Tripathi","sequence":"first","affiliation":[{"name":"Division of Cardiology \u00a0University of Kentucky College of Medicine, Bowling Green, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5055-3226","authenticated-orcid":false,"given":"Mohammad Saud","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Cardiology \u00a0University of Kentucky College of Medicine, Bowling Green, Kentucky, USA"},{"name":"Department of Cardiology \u00a0Cheyenne Regional Medical Center, Cheyenne, Wyoming, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur Rahman","family":"Khan","sequence":"additional","affiliation":[{"name":"Kornhauser Health Science Library \u00a0University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida M.","family":"Vaughn","sequence":"additional","affiliation":[{"name":"Kornhauser Health Science Library \u00a0University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bolli","sequence":"additional","affiliation":[{"name":"Institute of Molecular Cardiology \u00a0University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"issue":"10","key":"2022022811015607900_sct312985-bib-0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"2022022811015607900_sct312985-bib-0002","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ Res"},{"issue":"11","key":"2022022811015607900_sct312985-bib-0003","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jchf.2015.06.012","article-title":"Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy","volume":"3","author":"Shore","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"5","key":"2022022811015607900_sct312985-bib-0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ejhf.1461","article-title":"Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Seferovic","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2022022811015607900_sct312985-bib-0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2022022811015607900_sct312985-bib-0006","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2022022811015607900_sct312985-bib-0007","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"2022022811015607900_sct312985-bib-0008","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ Res"},{"issue":"6","key":"2022022811015607900_sct312985-bib-0009","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.113.300219","article-title":"Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Circ Res"},{"issue":"2","key":"2022022811015607900_sct312985-bib-0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","article-title":"New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types","volume":"123","author":"Wysoczynski","year":"2018","journal-title":"Circ Res"},{"key":"2022022811015607900_sct312985-bib-0011","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvab135","article-title":"Cell therapy in patients with heart failure: a comprehensive review and emerging concepts","author":"Bolli","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"8","key":"2022022811015607900_sct312985-bib-0012","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ Res"},{"issue":"5","key":"2022022811015607900_sct312985-bib-0013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","article-title":"A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy","volume":"2","author":"Fischer-Rasokat","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2022022811015607900_sct312985-bib-0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2008.06.002","article-title":"Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure","volume":"138","author":"Bocchi","year":"2010","journal-title":"Int J Cardiol"},{"issue":"44","key":"2022022811015607900_sct312985-bib-0015","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur Heart J"},{"issue":"42","key":"2022022811015607900_sct312985-bib-0016","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study)","volume":"36","author":"Martino","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"2022022811015607900_sct312985-bib-0017","first-page":"437","article-title":"Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial","volume":"29","author":"Sant'Anna","year":"2014","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"15","key":"2022022811015607900_sct312985-bib-0018","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","article-title":"The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study","volume":"55","author":"Seth","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2022022811015607900_sct312985-bib-0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ Res"},{"issue":"4","key":"2022022811015607900_sct312985-bib-0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","article-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy","volume":"17","author":"Vrtovec","year":"2011","journal-title":"J Card Fail"},{"issue":"11","key":"2022022811015607900_sct312985-bib-0021","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cjca.2014.03.026","article-title":"Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials","volume":"30","author":"Marquis-Gravel","year":"2014","journal-title":"Can J Cardiol"},{"issue":"1","key":"2022022811015607900_sct312985-bib-0022","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13287-016-0441-x","article-title":"A systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy","volume":"7","author":"Lu","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"2022022811015607900_sct312985-bib-0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12967-019-1966-4","article-title":"Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis","volume":"17","author":"Rong","year":"2019","journal-title":"J Transl Med"},{"issue":"12","key":"2022022811015607900_sct312985-bib-0024","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcyt.2020.06.006","article-title":"Effects of stem cells on non-ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Xia","year":"2020","journal-title":"Cytotherapy"},{"issue":"2","key":"2022022811015607900_sct312985-bib-0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","article-title":"Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial","volume":"120","author":"Butler","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"2022022811015607900_sct312985-bib-0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"A randomized comparative study on the efficacy of intracoronary infusion of autologous bone marrow mononuclear cells and mesenchymal stem cells in patients with dilated cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"Int Heart J"},{"key":"2022022811015607900_sct312985-bib-0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2022022811015607900_sct312985-bib-0028","volume-title":"Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen, Denmark: The Nordic Cochrane Centre TCC; 2014"},{"issue":"8","key":"2022022811015607900_sct312985-bib-0029","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.115.304554","article-title":"Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy","volume":"115","author":"Henry","year":"2014","journal-title":"Circ Res"},{"issue":"9","key":"2022022811015607900_sct312985-bib-0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5966\/sctm.2015-0070","article-title":"REVIVE trial: retrograde delivery of autologous bone marrow in patients with heart failure","volume":"4","author":"Patel","year":"2015","journal-title":"Stem Cells Translational Medicine"},{"issue":"10","key":"2022022811015607900_sct312985-bib-0031","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jacc.2006.04.104","article-title":"Evaluation of global and regional left ventricular function with 16-slice computed tomography, biplane cineventriculography, and two-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging","volume":"48","author":"Dewey","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2022022811015607900_sct312985-bib-0032","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.116.303614","article-title":"Use of mesenchymal stem cells for therapy of cardiac disease","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"2022022811015607900_sct312985-bib-0033","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2022022811015607900_sct312985-bib-0034","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm"},{"issue":"2","key":"2022022811015607900_sct312985-bib-0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/CIRCRESAHA.118.311207","article-title":"Enhancement strategies for cardiac regenerative cell therapy: focus on adult stem cells","volume":"123","author":"Broughton","year":"2018","journal-title":"Circ Res"},{"issue":"4","key":"2022022811015607900_sct312985-bib-0036","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/stem.2778","article-title":"Concise review: optimized strategies for stem cell-based therapy in myocardial repair: clinical translatability and potential limitation","volume":"36","author":"Wu","year":"2018","journal-title":"Stem Cells"},{"issue":"3","key":"2022022811015607900_sct312985-bib-0037","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1573403X12666160606121858","article-title":"Cellular therapy for heart failure","volume":"12","author":"Psaltis","year":"2016","journal-title":"Curr Cardiol Rev"},{"issue":"33","key":"2022022811015607900_sct312985-bib-0038","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/eurheartj\/ehx248","article-title":"Global position paper on cardiovascular regenerative medicine","volume":"38","author":"Fernandez-Aviles","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"2022022811015607900_sct312985-bib-0039","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2022022811015607900_sct312985-bib-0040","first-page":"1","article-title":"Efficacy and mode of action of mesenchymal stem cells in non-ischemic dilated cardiomyopathy: a systematic review","volume":"8","author":"Hoeeg","year":"2020","journal-title":"Biomedicine"},{"key":"2022022811015607900_sct312985-bib-0041","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fphys.2019.01182","article-title":"Mesenchymal stem cell secretion of SDF-1alpha modulates endothelial function in dilated cardiomyopathy","volume":"10","author":"Premer","year":"2019","journal-title":"Front Physiol"},{"key":"2022022811015607900_sct312985-bib-0042","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ebiom.2019.09.043","article-title":"Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy","volume":"48","author":"Rieger","year":"2019","journal-title":"EBioMedicine"},{"key":"2022022811015607900_sct312985-bib-0043","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"12","author":"Fisher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2022022811015607900_sct312985-bib-0044","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"issue":"10","key":"2022022811015607900_sct312985-bib-0045","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/sctm.21-0094","article-title":"Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Tripathi","year":"2021","journal-title":"STEM CELLS Transl Med"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/sctm.21-0094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/sctm.21-0094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/10\/1394\/42629724\/stcltm_10_10_1394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/10\/10\/1394\/42629724\/stcltm_10_10_1394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T11:28:22Z","timestamp":1646047702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/10\/10\/1394\/6515812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,8,4]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/sctm.21-0094","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"2021-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}